BioSpace News Archive

GE HealthCare Technologies Inc. announced the pricing of the previously announced secondary underwritten public offering of 14,000,000 shares of its common stock.

Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”) is excited to announce the highly anticipated release and availability of ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ (“PRIME”) bringing the FDA-approved oral testosterone replacement therapy (TRT) treatment to consumers across the U.S via its proprietary telehealth platform.

Helius Medical Technologies, Inc. today announced the initiation of an open-label study for its registrational program in stroke.

Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic manufacturing, announced an expansion of their partnership focused on development, manufacturing and clinical adoption of neurodegenerative disease assays.

Moleculin Biotech, Inc. today announced Jonathan Foster, Executive VP and Chief Financial Officer of Moleculin will participate in a fireside chat at the 36th Annual ROTH Conference on March 18, 2024 at 9:00 AM PT.

Baltimore-based biotechnology leader, Elixirgen Scientific, Inc., achieves ISO 9001:2015 Quality Management System certification, strengthening commitment to quality, excellence in biotechnology and drug discovery.

Avinger, Inc. today announced that it will release its financial results for the fourth quarter and full year 2023 after the close of trading on Wednesday, March 20, 2024.

Artelo Biosciences, Inc. today announced its selection as a finalist in Johnson & Johnson’s Innovation Challenge.

Paragonix Technologies, Inc. announces the landmark publication of the first clinical manuscript assessing the use of FDA-cleared advanced organ preservation technology to significantly extend ischemic times, a term referring to the sensitive window of time between organ recovery and transplantation.

Revelation Biosciences Inc. announced today that its Chief Executive Officer James Rolke will participate in a virtual fireside chat at the 36th Annual Roth Conference scheduled for March 17-19, 2023 to be held at The Ritz Carlton, Laguna Niguel in Dana Point, California.